Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Cardiovascular Disorders
Published in: BMC Cardiovascular Disorders 1/2017

Open Access 01-12-2017 | Research article

The association of sleep disordered breathing with left ventricular remodeling in CAD patients: a cross-sectional study

Authors: Audrius Alonderis, Nijole Raskauskiene, Vaidute Gelziniene, Narseta Mickuviene, Julija Brozaitiene

Published in: BMC Cardiovascular Disorders | Issue 1/2017

Login to get access

Abstract

Background

There is still insufficient knowledge on the potential effect of mild to moderate sleep-disordered breathing (SDB) that is widely prevalent, often asymptomatic, and largely undiagnosed in patients with stable coronary artery disease (CAD). SDB affects 34% of men and 17% of women aged between 30 and 70. The objective of this study was to evaluate the association between SDB and left ventricular (LV) hypertrophy as well as structural remodeling in stable CAD patients.

Methods

The study was based on a cross-sectional design. Echocardiography and polysomnography was performed in 772 patients with CAD and with untreated sleep apnea. All study participants underwent testing by Epworth Sleepiness Scale questionnaire. Their mean age, NYHA and left ventricular ejection fraction were, respectively: 57 ± 9 years, 2.1 ± 0.5 and 51 ± 8%, and 76% were men. Sleep apnea (SA) was defined as an apnea-hypopnea-index (AHI) ≥5 events/h, and, non-SA, as an AHI <5.

Results

Sleep apnea was present in 39% of patients, and a large fraction of those patients had no complaints on excessive daytime sleepiness. The patients with SA were older, with higher body mass and higher prevalence of hypertension. LV hypertrophy (LVH), defined by allometrically corrected (LV mass/height2.7) gender-independent criteria, was more common among the patients with SA than those without (86% vs. 74%, p < 0.001). The frequency of LVH by wall thickness criteria (interventricular septal thickness or posterior wall thickness ≥ 12 mm: 49% vs. 33%, p < 0.001) and concentric LVH (61% vs. 47%, p = 0.001) was higher in CAD patients with SA. The patients with SA had significantly higher values of both interventricular septal thickness and posterior wall thickness. Multiple logistic regression analysis showed that even mild sleep apnea was an independent predictor for LVH by wall thickness criteria and concentric LVH (OR = 1.5; 95% CI 1.04–2.2 and OR = 1.9; 1.3–2.9 respectively).

Conclusions

We concluded that unrecognized sleep apnea was highly prevalent among patients with stable CAD, and the majority of those patients did not report daytime sleepiness. Mild to moderate sleep apnea was associated with increased LV wall thickness, LV mass, and with higher prevalence of concentric LV hypertrophy independently of coexisting obesity, hypertension, diabetes mellitus or advancing age.
Literature
1.
Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet. 1999;353(9147):89–92.CrossRefPubMed
2.
3.
Konecny T, Kuniyoshi FH, Orban M, Pressman GS, Kara T, Gami A, et al. Under-diagnosis of sleep apnea in patients after acute myocardial infarction. J Am Coll Cardiol. 2010;56(9):742–3.CrossRefPubMedPubMedCentral
4.
Somers VK, White DP, Amin R. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation scientific statement from the American Heart Association Council for high blood pressure research professional education committee, council on clinical cardiology, stroke council, and council on cardiovascular nursing. Circulation. 2008;118:1080–1111.
5.
6.
Kasai T, Floras JS, Bradley TD. Sleep apnea and cardiovascular disease: a bidirectional relationship. Circulation. 2012;126(12):1495–510.CrossRefPubMed
7.
8.
Oldenburg O, Wellmann B, Buchholz A, Bitter T, Fox H, Thiem U, Horstkotte D, Wegscheider K. Nocturnal hypoxaemia is associated with increased mortality in stable heart failure patients. Eur Heart J. 2016 Jun 1;37(21):1695–703.CrossRefPubMed
9.
Iannaccone M, Quadri G, Taha S, D’Ascenzo F, Montefusco A, Omede P, et al. Prevalence and predictors of culprit plaque rupture at OCT in patients with coronary artery disease: a meta-analysis. Eur Heart J Cardiovasc Imaging. 2015;17:1128–37.CrossRefPubMed
10.
Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001;104(3):365–72.CrossRefPubMed
11.
12.
13.
14.
Gottlieb D, Yenokyan G, Newman A, O’Connor G, Punjabi N, Quan S, et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep hearth health study. Circulation. 2010;122:352–60.CrossRefPubMedPubMedCentral
15.
Hagenah GC, Gueven E, Andreas S. Influence of obstructive sleep apnoea in coronary artery disease: a 10-year follow-up. Respir Med. 2006;100(1):180–2.CrossRefPubMed
16.
Hedner J, Grote L, Bonsignore M, McNicholas W, Lavie P, Parati G, et al. The European sleep Apnoea database (ESADA): report from 22 European sleep laboratories. Eur Respir J. 2011;38:635–42.CrossRefPubMed
17.
Peker Y, Kraiczi H, Hedner J, Loth S, Johansson A, Bende M. An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J. 1999;14:179–84.CrossRefPubMed
18.
Artham SM, Lavie CJ, Milani RV, Patel DA, Verma A, Ventura HO. Clinical impact of left ventricular hypertrophy and implications for regression. Prog Cardiovasc Dis. 2009;52:153–67.CrossRefPubMed
19.
Lavie CJ, Milani RV, Shah SB, Gilliland Y, Bernal JA, et al. Impact of left ventricular geometry on prognosis—a review of Ochsner studies. Ochsner J. 2008;8:11–7.PubMedPubMedCentral
20.
Lavie CJ, Patel DA, Milani RV, Ventura HO, Shah S, Gilliland Y. Impact of echocardiographic left ventricular geometry on clinical prognosis. Prog Cardiovasc Dis. 2014;57(1):3–9.CrossRefPubMed
21.
Niroumand M, Kuperstein R, Sasson Z, Hanly PJ. Impact of obstructive sleep apnea on left ventricular mass and diastolic function. Am J Respir Crit Care Med. 2001;163:1632–6.CrossRefPubMed
22.
Noda A, Okada T, Yasuma F, Nakashima N, Yokota M. Cardiac hypertrophy in obstructive sleep apnea syndrome. Chest. 1995;107:1538–44.CrossRefPubMed
23.
Avelar E, Cloward TV, Walker JM, Farney RJ, Strong M, Pendleton RC, et al. Left ventricular hypertrophy in severe obesity: interaction among blood pressure, nocturnal hypoxemia and body mass. Hypertension. 2007;49:34–9.CrossRefPubMed
24.
Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N EnglJ Med. 2000;342:1378–84.CrossRef
25.
Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol Oxford University Press. 2013 May 1;177(9):1006–14.CrossRef
26.
Cioffi G, Russo TE, Stefenelli C, Selmi A, Furlanello F, Cramariuc D, Gerdts E, de Simone G. Severe obstructive sleep apnea elicits concentric left ventricular geometry. J Hypertens. 2010 May;28(5):1074–82.CrossRefPubMed
27.
Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992;19:1559–60.CrossRef
28.
Silangei LK, Maro VP, Diefethal H, Kapanda G, Dewhurst M, Mwandolela H, Hame B. Assessment of left ventricular geometrical patterns and function among hypertensive patients at a tertiary hospital. Northern Tanzania BMC Cardiovascular Disorders. 2012;12:109. https://​doi.​org/​10.​1186/​1471-2261-12-109.​
29.
Lauer MS, Anderson KM, Kannel WB, Levy D. The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study JAMA. 1991;266:231–6.PubMed
30.
Messerli FH, Sundgaard-Riise K, Reisin ED, Dreslinski GR, Ventura HO, Oigman W, Frohlich ED, Dunn FG. Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann Intern Med. 1983;99:757–61.CrossRefPubMed
31.
de Simone G, Devereux RB, Roman MJ, Alderman MH, Laragh JH. Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension. 1994;23:600–6.CrossRefPubMed
32.
de Simone G, Izzo R, De Luca N, Gerdts E. Left ventricular geometry in obesity: is it what we expect? Nutr Metab Cardiovasc Dis. 2013;23(10):905–12.CrossRefPubMed
33.
Aurigemma GP, de Simone G, Fitzgibbons TP. Cardiac remodeling in obesity. Circ Cardiovasc Imaging. 2013 Jan 1;6(1):142–52.CrossRefPubMed
34.
Iber C, Ancoli-Israel S, Chesson A, Quan SF. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. 1st ed. American Academy of Sleep Medicine: Westchester, Illinois; 2007.
35.
Johns MW. Daytime sleepiness, snoring and obstructive sleep apnea: the Epworth sleepiness scale. Chest. 1993;103:30–6.CrossRefPubMed
36.
Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography, American Society of Echocardiography Committee on Standards, Subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr. 1989;2:358–67.CrossRefPubMed
37.
Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450–8.CrossRefPubMed
38.
39.
Cuspidi C, Meani S, Negri F, Giudici V, Valerio C, Sala C, et al. Indexation of left ventricular mass to body surface area and height to allometric power of 2.7: Is the difference limited to obese hypertensives? J Hum Hypertens. 2009;23:728–734.
40.
Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–63.CrossRefPubMed
41.
Areias V, Romero J, Cunha K, Faria R, Mimoso J, Gomes V, et al. Sleep apnea-hypopnea syndrome and acute coronary syndrome an association not to forget. Rev Port Pneumol. 2012;18(1):22–8.CrossRefPubMed
42.
43.
Mooe T, Rabben T, Wiklund U, Franklin KA, Eriksson P. Sleep-disordered breathing in women: occurrence and association with coronary artery disease. Am J Med. 1996;101:251–6.CrossRefPubMed
44.
Moruzzi P, Sarzi-Braga S, Rossi M, Contini M. Sleep apnoea in ischaemic heart disease: differences between acute and chronic coronary syndromes. Heart. 1999;82(3):343–7.CrossRefPubMedPubMedCentral
45.
Bouloukaki I, Simantirakis E, Mermigis C, Arfanakis D, Chrysos-tomakis S, Kallergis E, et al. Sleep-disordered breathingin patients with acute coronary syndrome. J Sleep Res. 2010;19:296–7.
46.
Fox H, Purucker HC, Holzhacker I, Tebtmann U, Bitter T, Horstkotte D, Graml A, Woehrle H, Oldenburg O. Prevalence of sleep-disordered breathing and patient characteristics in a coronary artery disease cohort undergoing cardiovascular rehabilitation. J Cardiopulm Rehabil Prev. 2016 Nov/Dec;36(6):421–429.
47.
Arzt M, Woehrle H, Oldenburg O, Graml A, Suling A, Erdmann E, Teschler H, Wegscheider K. SchlaHF investigators. Prevalence and predictors of sleep-disordered breathing in patients with stable chronic heart failure: the SchlaHF registry. JACC Heart Fail. 2016 Feb;4(2):116–25.CrossRefPubMed
48.
Kraiczi H, Peker Y, Caidahl K, Samuelsson A, Hedner J. Blood pressure, cardiac structure and severity of obstructive sleep apnea in a sleep clinic population. J Hypertens. 2001;19:2071–8.CrossRefPubMed
49.
Cloward TV, Walker JM, Farney RJ, Anderson JL. Left ventricular hypertrophy is a common echocardiographic abnormality in severe obstructive sleep apnea and reverses with nasal continuous positive airway pressure. Chest. 2003;124:594–601.CrossRefPubMed
50.
MacMahon SW, Wilcken DE, Macdonald GJ. The effect of weight reduction on left ventricular mass: a randomized controlled trial in young, overweight hypertensive patients. N Engl J Med. 1986;314:334–9.CrossRefPubMed
51.
Drager LF, Bortolotto LA, Figueiredo AC, Figueiredo AC, Silva BC, Krieger EM, Lorenzi-Filho G. Obstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling. Chest. 2007;131:1379–86.CrossRefPubMed
52.
Marshall NS, Wong KKH, Phillips CL, Liu PY, Knuiman MW, Grunstein RR. Is sleep apnea an independent risk factor for prevalent and incident diabetes in the Busselton health study? J Clin Sleep Med. 2009;5:15–20.PubMedPubMedCentral
53.
Usui Y, Takata Y, Inoue Y, Katsunori S, Hirofumi T, et al. Coexistense of obstructive sleep apnoea and metabolic syndrome is independently associated with left ventricular hypertrophy and diastolic dysfunction. Sleep Breath. 2012;16(3):677–84.CrossRefPubMed
54.
Drager LF, Togeiro SM, Polotsky VY, Lorenzi-Filho G. Obstructive sleep apnoea: a cardiometabolic risk in obesity and the metabolic syndrome. J Am Coll Cardiol. 2013;62:569–76.CrossRefPubMedPubMedCentral
55.
Costa LE, Uchôa CH, Harmon RR, Bortolotto LA, Lorenzi-Filho G, Drager LF. Potential underdiagnosis of obstructive sleep apnoea in the cardiology outpatient setting. Heart. 2015;101:1288–92.CrossRefPubMed
56.
Fietze I, Penzel T, Alonderis A, Barbe F, Bonsignore MR, Carverly P, et al. Management of obstructive sleep apnea in Europe. Sleep Med. 2011;12:190–7.CrossRefPubMed
Metadata
Title
The association of sleep disordered breathing with left ventricular remodeling in CAD patients: a cross-sectional study
Authors
Audrius Alonderis
Nijole Raskauskiene
Vaidute Gelziniene
Narseta Mickuviene
Julija Brozaitiene
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2017
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-017-0684-1

Other articles of this Issue 1/2017

BMC Cardiovascular Disorders 1/2017 Go to the issue

Research article

Measurement of blood pressure for the diagnosis and management of hypertension in different ethnic groups: one size fits all

Research article

Impaired chronotropic response to physical activities in heart failure patients

Case report

Left ventricular non-compaction cardiomyopathy with coronary artery anomaly complicated by ventricular tachycardia

Research article

Migraine and percutaneous patent foramen ovale closure: a systematic review and meta-analysis

Research article

Prehypertension and psychosocial risk factors among university students in ASEAN countries

Research article

Metabolomic profiling in patients undergoing Off-Pump or On-Pump coronary artery bypass surgery

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits